1.225
Nuwellis Inc stock is traded at $1.225, with a volume of 32,065.
It is down -0.41% in the last 24 hours and down -2.78% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on advancing precision cardiorenal care in critical care settings through the development, manufacture, and commercialization of the Aquadex SmartFlow system for ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$1.23
Open:
$1.21
24h Volume:
32,065
Relative Volume:
0.02
Market Cap:
$3.23M
Revenue:
$8.27M
Net Income/Loss:
$-17.52M
P/E Ratio:
-0.0196
EPS:
-62.6089
Net Cash Flow:
$-10.90M
1W Performance:
+13.43%
1M Performance:
-2.78%
6M Performance:
-64.70%
1Y Performance:
+31.72%
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NUWE
Nuwellis Inc
|
1.225 | 3.24M | 8.27M | -17.52M | -10.90M | -62.61 |
|
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services - Bitget
Nuwellis retains CORE IR for investor relations services By Investing.com - Investing.com
Nuwellis brings in CORE IR to sharpen investor outreach and social media - Stock Titan
Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK
Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory - Bitget
Can Nuwellis Inc stock double in the next yearQuarterly Profit Review & Community Consensus Trade Alerts - baoquankhu1.vn
Nuwellis (NUWE) Expands Commercial Reach in South Texas - GuruFocus
South Texas hospitals get dedicated Nuwellis team for fluid care - Stock Titan
Nuwellis signs letter of intent to acquire Rendiatech - MSN
Nuwellis (NASDAQ: NUWE) outlines 2026 virtual meeting, director elections and auditor ratification - Stock Titan
Nuwellis, Inc. Form 8-K/A Filing Details, Company Information, and SEC Compliance Disclosures - Minichart
Former Nuwellis (NASDAQ: NUWE) directors submit response letters - Stock Titan
Nuwellis reports pediatric segment reaches 50% of U.S. revenue By Investing.com - Investing.com South Africa
Nuwellis Pediatric Business Continues Growth Momentum - Intellectia AI
In fiscal year 2025, the pediatric business segment under Nuwellis, Inc. demonstrated strong growth, with its sales revenue in the U.S. market approaching 50% of the company's total domestic revenue. - Bitget
Nuwellis reports pediatric segment reaches 50% of U.S. revenue - Investing.com
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone - Bitget
Nuwellis Pediatric Category Achieves Approximately 50% Of Total U.S. Revenue In 2025, Marking Growth Milestone - TradingView
Half of Nuwellis U.S. revenue now comes from pediatric care - Stock Titan
Macro Review: Is Nuwellis Inc forming a breakout pattern2026 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Nuwellis (LTS:0HQX) PE Ratio : N/A (As of Mar. 28, 2026) - GuruFocus
Nuwellis, Inc. Files Form 8-K Reporting Company Information and SEC Compliance Details - Minichart
Nuwellis announces resignations of two board members and reduces board size - Investing.com UK
Nuwellis Board Directors Resign Amid Governance Dispute - TipRanks
[8-K] Nuwellis, Inc. Reports Material Event - Stock Titan
Nuwellis Inc (NUWE) Stock Price & 30 Year Financial Data - GuruFocus
Risk Report: What is Nuwellis Incs 5 year growth outlook2026 Setups & Long-Term Capital Growth Ideas - baoquankhu1.vn
Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn
Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan
Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - Investing.com South Africa
CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com
Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com
Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com
Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart
Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus
Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks
Nuwellis Completes Acquisition of Rendiatech - Bitget
Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan
Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan
Nuwellis completes acquisition of Rendiatech - marketscreener.com
Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com
Nuwellis, Inc. 2026 Annual Report: Aquadex System Market, Risks, and Regulatory Overview - Minichart
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):